Resources

Fact Sheet: Highly sensitive tests for malaria- Identifying the final cases in areas close to elimination

PATH and Sinapi Biomedical, South Africa, developed the first low-cost, fully assembled uterine balloon tamponade device to help protect women from the leading cause of maternal death, post-partum hemorrhage. The Ellavi UBT is preassembled device used in multiple countries to manage postpartum hemorrhage.In 2020, Harvard University researcher, Elizabeth Pylant Bransford Maxwell, authored a study: "A Comparative Analysis of User Experience With Uterine Balloon Devices During Standardized Postpartum Hemorrhage Simulations" which showed the Ellavi UBT to be the "simplest, easiest, and fastest device to use overall."

Fact Sheet: Point-of-care tools for malaria care - Determining glucose-6-phosphate dehydrogenase (G6PD) deficiency to guide patient treatment for Plasmodium vivax

Fact Sheet: Developing new diagnostic tools to improve preeclampsia screening

This year’s annual report features our annual financial overview, a list of PATH’s funders and supporters, and our accomplishments in 2020.